Daily News Archive
Daily News Subscription
Promising New Drug Research in USA
The Gluck Equine Research Foundation, based at the University of Kentucky, has received a $100,000 grant from Stonestreet Farm to develop an equine biological passport (EBP), reports bloodhorse.com. "In the last few years we have seen too many negative headlines around equine drug use. As a research scientist, with 30 years of regulatory drug testing experience, my team and I know this is a problem we cannot currently solve," said Dr. Scott Stanley, professor of Equine Pharmacology and Toxicology and director of the Equine Analytical Chemistry Laboratory. "We know that it takes time to develop new tests for each new emerging drug, so we will always be behind. We know that each horse metabolizes drugs at a different rate, making standard clearance and withdrawal times confusing. In addition, we know that there are environmental factors, human interactions, and hundreds of other variables that can impact our current drug testing procedures." The passport aims to improve drug testing protocol and further understand the impact of drugs on Thoroughbred horses. "The EBP program is a tool that will enable us to rapidly identify new drugs and measure the physiological effect on the equine athlete," Stanley continued. "These data will be critical in differentiating between intentional doping and accidental contaminants, which can smear the industry image and damage reputations."